Northwest Biotherapeutics, Inc.
Hedge Funds Holdings

Last updated:

Northwest Biotherapeutics, Inc.‘s stocks are currently a part of 10 hedge funds’ portfolios, which represents 48.61% of the total amount of its stocks outstanding. This makes up a total of 493.78K shares of Northwest Biotherapeutics, Inc.. Compared to the previous quarter, the number fell by -82.45% or -2.31M shares fewer. As for the holding position changes, 10% (1) of current holders sold a part of the shares held, and 10% (1) closed the holdings completely. 1 hedge funds are new holders of Northwest Biotherapeutics, Inc. stock in Q1 2023, it is 10% of total holders.

Hedge funds holding Northwest Biotherapeutics (Q2 2018 – Q1 2023)

Number of hedge funds
Q2 2018 4
Q3 2018 4
Q4 2018 6
Q1 2019 5
Q2 2019 6
Q3 2019 5
Q4 2019 4
Q1 2020 6
Q2 2020 5
Q3 2020 5
Q4 2020 8
Q1 2021 10
Q2 2021 13
Q3 2021 10
Q4 2021 12
Q1 2022 13
Q2 2022 12
Q3 2022 11
Q4 2022 13
Q1 2023 10

Hedge funds changes in Northwest Biotherapeutics positions (Q2 2018 – Q1 2023)

Changes in positions
Q2 2018 00004
Q3 2018 01003
Q4 2018 20004
Q1 2019 11021
Q2 2019 11103
Q3 2019 10022
Q4 2019 00013
Q1 2020 20004
Q2 2020 11021
Q3 2020 03002
Q4 2020 33011
Q1 2021 23104
Q2 2021 42016
Q3 2021 01135
Q4 2021 23007
Q1 2022 21118
Q2 2022 04116
Q3 2022 11126
Q4 2022 25006
Q1 2023 10117

Top 50 hedge fund holders of Northwest Biotherapeutics, Inc. (OTC:NWBO)

Hedge fund Value Shares owned Portfolio share
SENTINUS, LLC 1.01M 1.19M 0.636%
ANCORA ADVISORS, LLC 355K 497K 0.011%
MOLONEY SECURITIES ASSET MANAGEMENT, LLC 204K 285.16K 0.049%
OPUS CAPITAL GROUP, LLC 39K 55.15K 0.009%
WILLIAMS JONES WEALTH MANAGEMENT, LLC. 28K 39K 0.001%
LEE DANNER & BASS INC 14K 20K 0.002%
GRACE & WHITE INC /NY 10K 14.70K 0.002%
GOFEN & GLOSSBERG LLC /IL/ 9K 12.74K 0.000%
ESTABROOK CAPITAL MANAGEMENT 4.99K 7K 0.001%
BARTLETT & CO. LLC 3K 4.29K 0.000%
ALMANACK INVESTMENT PARTNERS, LLC. 0 0 0.000%
CAPTRUST FINANCIAL ADVISORS 0 0 0.000%